<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04740008</url>
  </required_header>
  <id_info>
    <org_study_id>SPH-2020-29384</org_study_id>
    <secondary_id>2020LS214</secondary_id>
    <nct_id>NCT04740008</nct_id>
  </id_info>
  <brief_title>Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices</brief_title>
  <official_title>Impact of Low Nicotine Cigarette Messaging on Risk Perceptions and Hypothetical Tobacco and Nicotine Product Choices.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masonic Cancer Center, University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Masonic Cancer Center, University of Minnesota</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to evaluate the effects of low nicotine content cigarette&#xD;
      (LNC) educational messaging on perceptions of low nicotine cigarettes, tobacco/nicotine&#xD;
      product choice preferences (hypothetical), LNC cigarette subjective ratings, and LNC&#xD;
      cigarette abuse liability among adult smokers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized single-site study will assess the subject's risk perceptions and hypothetical&#xD;
      tobacco product choices based on their exposure to an educational messaging condition related&#xD;
      to nicotine content in cigarettes.&#xD;
&#xD;
      Subjects (N=40 in each group) will be given a pack of low nicotine content cigarettes (LNC;&#xD;
      0.4 mg/g) and will be randomly assigned to read one of two messaging conditions on low&#xD;
      nicotine cigarettes.&#xD;
&#xD;
      Smokers will undergo a telephone screening to assess eligibility, then move on to the next&#xD;
      steps of the study depending on eligibility:&#xD;
&#xD;
        1. Virtual Zoom Screening - Completed after telephone screen: Informed consent is obtained&#xD;
           and then an interview where data is collected and eligibility is further assessed.&#xD;
&#xD;
        2. Curbside Visit - Completed after the screening and if eligible: Breath test, and if&#xD;
           necessary a urine test, is performed to assess smoking levels and urine pregnancy test&#xD;
           is attained (if applicable). If eligible, randomization to messaging condition occurs&#xD;
           and participants provided a pack of low nicotine content cigarettes.&#xD;
&#xD;
        3. Virtual Zoom Home Session - Completed after curbside and if eligible based on curbside:&#xD;
           Surveys assessing main outcome variables assessed.&#xD;
&#xD;
        4. Follow-up - Completed 1 week after the virtual Zoom session: Interview where assessment&#xD;
           of health and product usage is assessed.&#xD;
&#xD;
      Except for the initial telephone screening, participants will receive compensation for each&#xD;
      part of the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2021</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of participants that choose ANDS or no tobacco</measure>
    <time_frame>Within 17 days of virtual screening</time_frame>
    <description>Proportion of participants who select to use ANDS or no tobacco if LNC cigarettes were the only cigarettes available will be compared in arm 1 versus arm 2</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Smoking</condition>
  <condition>Cigarette</condition>
  <arm_group>
    <arm_group_label>Control message on low nicotine cigarettes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Test message on low nicotine cigarettes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low Nicotine Content Cigarettes</intervention_name>
    <description>Low Nicotine Content Cigarettes 0.4 mg/g nicotine; 9 mg tar Other Name: Reduced Nicotine Content Cigarettes</description>
    <arm_group_label>Control message on low nicotine cigarettes</arm_group_label>
    <arm_group_label>Test message on low nicotine cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control message</intervention_name>
    <description>Participants will read control message</description>
    <arm_group_label>Control message on low nicotine cigarettes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test message</intervention_name>
    <description>Participants will read test message</description>
    <arm_group_label>Test message on low nicotine cigarettes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  At least 21 years of age&#xD;
&#xD;
          -  Biochemically confirmed smoker&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable health condition&#xD;
&#xD;
          -  Unstable medications&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
&#xD;
          -  Unreliable access to a computer, smart phone or tablet without working camera and&#xD;
             internet access for telehealth visits and online questionnaires&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Mowls Carroll, Ph.D., M.P.H</last_name>
    <role>Principal Investigator</role>
    <affiliation>Masonic Cancer Center, University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MacKenzie Differding, BS</last_name>
    <phone>6126244913</phone>
    <email>diffe005@umn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Minnesota, Tobacco Research Program, 717 Delaware St., SE</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2021</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Low Nicotine Content</keyword>
  <keyword>Educational Messaging</keyword>
  <keyword>Cigarette</keyword>
  <keyword>Smoking</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Intend to share findings from this research through publications and presentations. Institutions and individuals wishing to access any resources or data must contact the Principal Investigator (Carroll). Data will be available in two formats. One will be a summary of the data, with graphs and tables, posted as pdf files and as raw individual-level data for analysis. Data generated by this grant will be made to outside investigators, according to NIH Guidance. When data are shared, there will be no limits placed on how the data will be used. Users will agree, however, that the recipient must not transfer the data to other users and that the data are only to be used for research purposes. A record of transfer of data and a copy of the dataset that was distributed will be kept by University of Minnesota</ipd_description>
    <ipd_time_frame>Data will not be available until primary and secondary papers are accepted for publication.</ipd_time_frame>
    <ipd_access_criteria>Persons requesting data must do so in writing, identifying their affiliation and how the data will be used. Upon review, access will be determined.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

